Amneal Pharmaceuticals Statistics
Total Valuation
AMRX has a market cap or net worth of $2.38 billion. The enterprise value is $4.90 billion.
Important Dates
The last earnings date was Friday, May 2, 2025, before market open.
| Earnings Date | May 2, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AMRX has 313.42 million shares outstanding. The number of shares has increased by 44.20% in one year.
| Current Share Class | 313.42M |
| Shares Outstanding | 313.42M |
| Shares Change (YoY) | +44.20% |
| Shares Change (QoQ) | +4.55% |
| Owned by Insiders (%) | 48.76% |
| Owned by Institutions (%) | 41.42% |
| Float | 160.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 11.38 |
| PS Ratio | 0.83 |
| Forward PS | 1.07 |
| PB Ratio | -40.11 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 9.82 |
| P/OCF Ratio | 7.76 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 8.10, with an EV/FCF ratio of 20.20.
| EV / Earnings | n/a |
| EV / Sales | 1.73 |
| EV / EBITDA | 8.10 |
| EV / EBIT | 13.45 |
| EV / FCF | 20.20 |
Financial Position
The company has a current ratio of 1.40
| Current Ratio | 1.40 |
| Quick Ratio | 0.80 |
| Debt / Equity | n/a |
| Debt / EBITDA | 4.12 |
| Debt / FCF | 10.64 |
| Interest Coverage | 1.46 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 6.67% |
| Return on Invested Capital (ROIC) | 8.67% |
| Return on Capital Employed (ROCE) | 15.91% |
| Revenue Per Employee | $340,986 |
| Profits Per Employee | -$1,572 |
| Employee Count | 8,300 |
| Asset Turnover | 0.83 |
| Inventory Turnover | 3.07 |
Taxes
In the past 12 months, AMRX has paid $25.58 million in taxes.
| Income Tax | 25.58M |
| Effective Tax Rate | 44.10% |
Stock Price Statistics
The stock price has increased by +14.11% in the last 52 weeks. The beta is 1.17, so AMRX's price volatility has been higher than the market average.
| Beta (5Y) | 1.17 |
| 52-Week Price Change | +14.11% |
| 50-Day Moving Average | 7.97 |
| 200-Day Moving Average | 8.17 |
| Relative Strength Index (RSI) | 50.41 |
| Average Volume (20 Days) | 2,109,591 |
Short Selling Information
The latest short interest is 6.10 million, so 1.95% of the outstanding shares have been sold short.
| Short Interest | 6.10M |
| Short Previous Month | 4.43M |
| Short % of Shares Out | 1.95% |
| Short % of Float | 3.80% |
| Short Ratio (days to cover) | 3.02 |
Income Statement
In the last 12 months, AMRX had revenue of $2.83 billion and -$13.05 million in losses. Loss per share was -$0.04.
| Revenue | 2.83B |
| Gross Profit | 1.03B |
| Operating Income | 364.20M |
| Pretax Income | -55.01M |
| Net Income | -13.05M |
| EBITDA | 605.02M |
| EBIT | 364.20M |
| Loss Per Share | -$0.04 |
Full Income StatementBalance Sheet
The company has $61.63 million in cash and $2.58 billion in debt, giving a net cash position of -$2.52 billion or -$8.03 per share.
| Cash & Cash Equivalents | 61.63M |
| Total Debt | 2.58B |
| Net Cash | -2.52B |
| Net Cash Per Share | -$8.03 |
| Equity (Book Value) | -59.39M |
| Book Value Per Share | -0.42 |
| Working Capital | 434.63M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $306.92 million and capital expenditures -$64.40 million, giving a free cash flow of $242.52 million.
| Operating Cash Flow | 306.92M |
| Capital Expenditures | -64.40M |
| Free Cash Flow | 242.52M |
| FCF Per Share | $0.77 |
Full Cash Flow StatementMargins
Gross margin is 36.48%, with operating and profit margins of 12.87% and -0.46%.
| Gross Margin | 36.48% |
| Operating Margin | 12.87% |
| Pretax Margin | 2.05% |
| Profit Margin | -0.46% |
| EBITDA Margin | 21.38% |
| EBIT Margin | 12.87% |
| FCF Margin | 8.57% |
Dividends & Yields
AMRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -44.20% |
| Shareholder Yield | -44.20% |
| Earnings Yield | -0.55% |
| FCF Yield | 10.18% |
Dividend DetailsAnalyst Forecast
The average price target for AMRX is $10.80, which is 42.11% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.80 |
| Price Target Difference | 42.11% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AMRX has an Altman Z-Score of 1.52 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.52 |
| Piotroski F-Score | 5 |